论文部分内容阅读
目的:观察黄芪注射液与血栓通注射液联合应用治疗急性脑梗死的疗效。方法:将78例急性脑梗死患者随机分为治疗组和对照组各39例,2组均给予西医的常规治疗,治疗组在对照组的基础上加用黄芪注射液与血栓通注射液,观察2组症状、生活能力状态、疗效及血液流变等变化情况。结果:治疗组的总有效率及神经功能缺损程度评分及血液流变学指标的改善程度均优于对照组,治疗后2组神经功能缺损评分均明显下降,与治疗前比较,差异有显著性意义(P<0.05);治疗组评分下降更为显著,与对照组治疗后比较,差异有显著性意义(P<0.01)。治疗后治疗组血液流变学指标(血浆黏度、血浆纤维蛋白原)均较治疗前明显降低(P<0.05),对照组上述指标则改变不明显(P>0.05)。结论:联合应用黄芪注射液与血栓通注射液治疗急性脑梗死疗效满意。
Objective: To observe the curative effect of combining Astragalus injection and Xueshuantong injection on acute cerebral infarction. Methods: A total of 78 patients with acute cerebral infarction were randomly divided into treatment group and control group, 39 cases in each group. Both groups were treated routinely with Western medicine. The treatment group was given Astragalus injection and Xueshuantong injection on the basis of the control group. 2 groups of symptoms, viability status, efficacy and blood rheology and other changes. Results: The total effective rate, the degree of neurological deficit and the improvement of hemorheology indexes in the treatment group were better than those in the control group. The neurological deficit scores of the two groups were significantly decreased after treatment, which were significantly different from those before treatment (P <0.05). The score of the treatment group decreased more significantly than that of the control group (P <0.01). After treatment, the indexes of hemorheology (plasma viscosity and plasma fibrinogen) of the treatment group were significantly lower than those before treatment (P <0.05), while those of the control group did not change significantly (P> 0.05). Conclusion: The combination of Astragalus injection and Xueshuantong injection in treating acute cerebral infarction is effective.